Search

everythinglearnresearchcommunity

for

Search:↓

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Drug addicts often have scars, skin color changes, blocked veins, and bruising, with severe ulcers from barbiturate injections.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Minoxidil keeps most hair growth from first year and twice-daily use is better with few side effects.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hormonal therapies are safe and effective for treating adult women's acne.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.